Japan finds risk factors associated with waning immunity of Pfizer vaccine

Japan |  News | 0 Comment | 22 Nov, 2021

New research from Japan, led by Jichi Medical University, has found several risk factors associated with greater wa...Read more

Japan-based Terumo Corp to expand diabetes care offerings

Japan |  News | 0 Comment | 18 Nov, 2021

Terumo Corporation, based in Japan, and the French company Diabeloop, have signed an agreement for a comprehensive strat...Read more

First integration of health management app and CGM data in Japan

Japan |  News | 0 Comment | 17 Nov, 2021

Health2Sync has announced to launch a new version of its mobile app that integrates continuous glucose monitor...Read more

Japan to buy 1.6M courses of Merck's COVID-19 pill

Japan |  News | 0 Comment | 11 Nov, 2021

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that the Japanese...Read more

Onlab Bio Dementia calls for Japanese and global startups

Japan |  News | 0 Comment | 08 Nov, 2021

Eisai has launched the “Open Network Lab BioHealth Dementia Innovation Challenge (Onlab Bio Dementia)”, a co...Read more

Japan's GHIT Fund invests $6.6M in new partnerships for life-saving drugs

Japan |  News | 0 Comment | 05 Nov, 2021

The Global Health Innovative Technology (GHIT) Fund in Japan has announced a total of approximately 750 million yen...Read more

Japan's Yokogawa announces new acquisition to build bioprocess solutions

Japan |  News | 0 Comment | 03 Nov, 2021

Japan-based Yokogawa Electric Corporation has acquired all shares of Insilico Biotechnology AG, a Germany-based develope...Read more

Japan's venture capitalism elevates deep-tech startups in Southeast Asia region

Japan |  Opinion | By Hithaishi C Bhaksar | 0 Comment | 02 Nov, 2021

Venture capitals play a major role in providing financial support to startup companies through strategic investments/men...Read more

Japan offers new treatment option for brain cancer

Japan |  News | 0 Comment | 02 Nov, 2021

Japanese firm Daiichi Sankyo Company has launched DELYTACT® (teserpaturev/G47∆), an oncolytic virus developed by t...Read more

Japan's Takeda makes new deal to accelerate gamma-delta T cell-based therapies

Japan |  News | 0 Comment | 28 Oct, 2021

Japanese firm Takeda Pharmaceutical has announced the exercise of its option to acquire UK-based GammaDelta Therape...Read more

Japan proposes drug cocktail to stop SARS-CoV-2 infection of stem cells

Japan |  News | 0 Comment | 27 Oct, 2021

A team of scientists at the Center for iPS Cell Research and Application (CiRA), Kyoto University in Japan, has sho...Read more

Daiichi Sankyo to commercialize mRNA COVID-19 vaccine in Japan within 2022

Japan |  News | 0 Comment | 26 Oct, 2021

Daiichi Sankyo has announced the progress of development of DS-5670, an mRNA vaccine in Japan, being evaluated against t...Read more

Japan brings highly sensitive bio-technology to detect SARS-CoV-2

Japan |  News | 0 Comment | 25 Oct, 2021

Tokai University, Toyohashi University of Technology, Chubu University, and DENSO Corporation in Japan have been develop...Read more

Fujitsu to offer AI-based personalised cancer treatment in Japan

Japan |  News | 0 Comment | 22 Oct, 2021

Aichi Cancer Center and Fujitsu have announced the development of an artificial intelligence (AI) based solution ab...Read more

Japan emphasises on escalating global anxiety and depression crisis

Japan |  News | 0 Comment | 19 Oct, 2021

Japanese firm Sumitomo Dainippon Pharma and US-based BehaVR, Inc. have signed definitive agreements to develop and ...Read more

Japan identifies molecules for building stronger antibodies

Japan |  News | 0 Comment | 15 Oct, 2021

A team of researchers at the Institute for the Advanced Study of Human Biology (ASHBi) at Kyoto University, Japan&n...Read more

Japan develops ML-based screening tool for cervical myelopathy

Japan |  News | 0 Comment | 13 Oct, 2021

A research team from Tokyo Medical and Dental University and Keio University in Japan combined a finger motion analysis ...Read more

Mass spec technology by Shimadzu unveils novel approach for immunotherapy success

Japan |  News | 0 Comment | 11 Oct, 2021

Japan's Shimadzu Corporation collaborated with Drs William Redmond and Yoshinobu Koguchi of the Providence Cancer Instit...Read more